Literature DB >> 3278952

Lipid peroxidation and endothelial cell injury: implications in atherosclerosis.

B Hennig1, C K Chow.   

Abstract

Vascular endothelial cells, which play an active role in the physiological processes of vessel tone regulation and vascular permeability, form a border separating deeper layers of the blood vessel wall and cellular interstitial space from the blood and circulating cells. Damage or dysfunction of endothelial cells may reduce the effectiveness of the endothelium to act as a selectively permeable barrier to plasma components, including cholesterol-rich lipoprotein remnants. This may be involved in the etiology of atherosclerosis. Experimental evidence indicates that free radical-mediated lipid peroxidation can induce endothelial cell injury/dysfunction. Reactive oxygen species, including peroxidized lipids capable of initiating cell injury, may be generated within endothelial cells, be present in plasma components, or be derived from neutrophils or other blood-borne cells. Lipid peroxidation could initiate or promote the process of atherosclerotic lesion formation by directly damaging endothelial cells, and by enhancing the adhesion and activation of neutrophils and the susceptibility of platelets to aggregate. Endothelial cell injury by lipid hydroperoxides also could increase the uptake of LDL into the vessel wall. These events and other cellular dysfunctions may individually or collectively initiate and/or help to sustain the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278952     DOI: 10.1016/0891-5849(88)90070-6

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  39 in total

1.  Interleukin-4, Oxidative Stress, Vascular Inflammation and Atherosclerosis.

Authors:  Yong Woo Lee; Paul H Kim; Won Hee Lee; Anjali A Hirani
Journal:  Biomol Ther (Seoul)       Date:  2010-04       Impact factor: 4.634

Review 2.  The chemistry and antioxidant properties of tocopherols and tocotrienols.

Authors:  A Kamal-Eldin; L A Appelqvist
Journal:  Lipids       Date:  1996-07       Impact factor: 1.880

3.  Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.

Authors:  B M Kromer; J R Tippins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium.

Authors:  Yong Woo Lee; Won Hee Lee; Paul H Kim
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

5.  Modulation of arterial endothelial permeability: studies on an in vitro model.

Authors:  J R Gudgeon; W Martin
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

6.  Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits.

Authors:  George S G Shehatou; Ghada M Suddek
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-20

7.  Correlation between CD11b/CD18 and increase of aggregability of granulocytes in coronary artery disease.

Authors:  A Mazzone; D Pasotti; S De Servi; G Fossati; I Hazzucchelli; P Cavigliano; G Ricevuti
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

8.  Effects of grape pomace on the antioxidant defense system in diet-induced hypercholesterolemic rabbits.

Authors:  Chang-Sook Choi; Hae-Kyung Chung; Mi-Kyung Choi; Myung-Hwa Kang
Journal:  Nutr Res Pract       Date:  2010-04-28       Impact factor: 1.926

9.  Lipid antioxidants: free radical scavenging versus regulation of enzymatic lipid peroxidation.

Authors:  Alejandro K Samhan-Arias; Yulia Y Tyurina; Valerian E Kagan
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

10.  Abnormal glutathione metabolism and increased cytotoxicity caused by H2O2 in human umbilical vein endothelial cells cultured in high glucose medium.

Authors:  A Kashiwagi; T Asahina; M Ikebuchi; Y Tanaka; Y Takagi; Y Nishio; R Kikkawa; Y Shigeta
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.